2022
Strides Pharma Inc. Notice of Potential 340B Refunds (PDF - 653 KB)
Purdue Pharma LP/Avrio Health LP/Adlon Therapeutics LP Notice of recalculated ceiling prices for Q2 2005-Q2 2021 (PDF - 165 KB)
Eli Lilly Notice of Changes to 2nd Quarter 2019 340B Ceiling Prices (PDF - 115 KB)
Novo Nordisk Inc. Notice Regarding Adjustment of 340B Prices for Select Products (PDF - 103 KB)
e5 Pharma Notice of Offer of Refunds (PDF - 186 KB)
Merck Notice to Offer Refunds (PDF - 149 KB)
BMS Notice regarding 340B Price Adjustments (PDF - 78 KB)
MNK Spec GX Notice of Recalculated 340B Ceiling Prices (PDF - 178 KB)
GSK Notice Regarding Offer of Refunds to 340B Covered Entities (PDF - 133 KB)
Amgen Notice Regarding Refunds to 340B Covered Entities (PDF - 149 KB)
Astellas Notice of Recalculated 340B Ceiling Prices 3Q21-2Q22 (PDF - 130 KB)
BioComp Notice to Covered Entities (PDF - 197 KB)
BMS Refund to 340B Covered Entities (PDF - 72 KB)
Eli Lilly Notice of Changes to 3rd Quarter 2019 340B Ceiling Prices (PDF - 116 KB)
Kala Notice to Refund Covered Entities (PDF - 90 KB)
J&J Notice of Refunds for Q3 and Q4 2019 (PDF - 74 KB)
Akorn Offer of Refund Notice (PDF - 431 KB)
Merck Notice to Offer Refunds (PDF - 184 KB)
Eli Lilly Notice of Changes to Second Quarter 2019 340B Prices (PDF - 136 KB)
GSK Notice Regarding Offer of Refunds to 340B Covered Entities (PDF - 386 KB)
Notice of Adjustment to 340B Price for Vertex Pharmaceuticals' Trikafta® (PDF - 104 KB)
NovoNordisk Notice of Refunds to 340B Covered Entities (PDF - 77 KB)
BMS Notice to Covered Entities of Refunds to 340B Covered Entities (PDF - 145 KB)
Notice of Partial Refund Ipsen's Somatuline® Depot (PDF - 139 KB)
Accessibility
If you use assistive technology, you may not be able to fully access information in these files. For assistance, please email 340B-Communication@hrsa.gov.